1) Findings: Insights and developments globally on the subject of cancer.
2) Companies: Updates and progress reports on Consortium member companies.
3) Industry: Important developments from throughout the field of cancer.
A new study suggests that a person’s risk of progressing from a benign condition called monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma, a type of blood cancer, can change over time. On average, […]
One property of cancer cells that can help them gain and maintain a foothold in the body is their ability to evade detection and destruction by the human immune system. Some tumor cells, […]
Drugs known as PARP inhibitors are used to treat some women with advanced ovarian cancer that has returned after earlier treatment. Now, results from three new clinical trials show that the drugs […]
New results from a large clinical trial show that the immunotherapy drug durvalumab (Imfinzi) can prolong survival in some people with advanced small cell lung cancer (SCLC). In the study, treatment with durvalumab combined with a standard […]
Waiting for medical results is like watching a pot that doesn’t want to boil. When diagnosing lung cancer, many people are left waiting for what seems like an eternity. And once the results […]
The drug tamoxifen can help prevent breast cancer in women at an increased risk of the disease. But many women who stand to benefit from tamoxifen do not take the drug—a pill—because […]
Paige, a New York-based company, is working to revolutionize the diagnosis and treatment of cancer by providing pathologists, clinicians and researchers with insights drawn from decades of data diagnosed by world experts […]
Tests for inherited genetic mutations can provide women diagnosed with ovarian or breast cancer with important information that can have implications for family members and potentially guide treatment decisions and longer-term screening […]
